Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Hanai

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical and Experimental Hematopathology : JCEH|March 11, 2026
Diffuse Large B-cell Lymphoma Complicated by Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity on Day 355 of Epcoritamab Therapy: A Case ReportYasunobu Sekiguchi, Kosuke Arai, Shizuka Hamano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2026
A Case of Diffuse Large B-Cell Lymphoma(DLBCL)Who Died of Acute Exacerbation of Interstitial Pneumonia after Treatment with R-mini-CHP in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP)Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 24, 2025
Efficacy and safety of Pola-R-mini-CHP therapy in patients aged ≥80 years with CD5-positive diffuse large B-Cell lymphomaKosuke Arai, Yasunobu Sekiguchi, Shizuka Hamano, et al.
Internal Medicine (Tokyo, Japan)|December 10, 2025
A Retrospective Study of the Efficacy and Safety of Epcoritamab in Real-world Clinical Practice: An Analysis of 19 Cases from a Single InstitutionYasunobu Sekiguchi, Shizuka Hamano, Kosuke Arai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 6, 2025
[Efficacy and Safety of R‒mini‒CHP Combined with Polatuzumab‒Vedotin Used for Previously Untreated Diffuse Large B‒Cell Lymphoma in Very Elderly Patients Aged ≥80 Years-A Single‒Center Retrospective Analysis]Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical and Experimental Hematopathology : JCEH|March 11, 2026
Diffuse Large B-cell Lymphoma Complicated by Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity on Day 355 of Epcoritamab Therapy: A Case ReportYasunobu Sekiguchi, Kosuke Arai, Shizuka Hamano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2026
A Case of Diffuse Large B-Cell Lymphoma(DLBCL)Who Died of Acute Exacerbation of Interstitial Pneumonia after Treatment with R-mini-CHP in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP)Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 24, 2025
Efficacy and safety of Pola-R-mini-CHP therapy in patients aged ≥80 years with CD5-positive diffuse large B-Cell lymphomaKosuke Arai, Yasunobu Sekiguchi, Shizuka Hamano, et al.
Internal Medicine (Tokyo, Japan)|December 10, 2025
A Retrospective Study of the Efficacy and Safety of Epcoritamab in Real-world Clinical Practice: An Analysis of 19 Cases from a Single InstitutionYasunobu Sekiguchi, Shizuka Hamano, Kosuke Arai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 6, 2025
[Efficacy and Safety of R‒mini‒CHP Combined with Polatuzumab‒Vedotin Used for Previously Untreated Diffuse Large B‒Cell Lymphoma in Very Elderly Patients Aged ≥80 Years-A Single‒Center Retrospective Analysis]Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, et al.
Pageof 2